Skip to main content

Peer Review reports

From: Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response

Original Submission
15 Sep 2020 Submitted Original manuscript
30 Sep 2020 Author responded Author comments - Aliza Mohd Yacob
Resubmission - Version 2
30 Sep 2020 Submitted Manuscript version 2
7 Jan 2021 Reviewed Reviewer Report
8 Jan 2021 Reviewed Reviewer Report
10 May 2021 Reviewed Reviewer Report
14 Jul 2021 Author responded Author comments - Aliza Mohd Yacob
Resubmission - Version 3
14 Jul 2021 Submitted Manuscript version 3
2 Aug 2021 Reviewed Reviewer Report
10 Aug 2021 Reviewed Reviewer Report
17 Sep 2021 Author responded Author comments - Aliza Mohd Yacob
Resubmission - Version 4
17 Sep 2021 Submitted Manuscript version 4
9 Dec 2021 Reviewed Reviewer Report
10 Feb 2022 Author responded Author comments - Aliza Mohd Yacob
Resubmission - Version 5
10 Feb 2022 Submitted Manuscript version 5
24 Feb 2022 Reviewed Reviewer Report
6 Mar 2022 Author responded Author comments - Aliza Mohd Yacob
Resubmission - Version 6
6 Mar 2022 Submitted Manuscript version 6
Publishing
9 Mar 2022 Editorially accepted
26 Mar 2022 Article published 10.1186/s12885-022-09396-5

You can find further information about peer review here.

Back to article page